Luca Bertamini, Carolina Terragna, Niccolò Bolli, Philippe Moreau, Paula Rodriguez-Otero, Mario Boccadoro, Joan Bladé, Niels W.C.J. van de Donk, Francesca Gay, Roberto Mina, Aurore Perrot, P. Joy Ho, Annemiek Broijl, Meral Beksac, Mark van Duin, Diego Vieyra, Fredrik Borgsten, Melissa Rowe, Meletios A. Dimopoulos, Pieter Sonneveld. "New IMS/IMWG risk criteria by next-generation sequencing (NGS): Analysis of daratumumab benefit in both high- and standard-risk patients (pts) in the PERSEUS study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7505